Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Apr;36(4):733-42.

Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation

Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation

W König et al. Immunology. 1979 Apr.

Abstract

An eosinophil chemotactic factor(s) (ECF) can be generated from human polymorphonuclear neutrophils by the calcium ionophore, phagocytosis, arachidonic acid and hypotonic lysis. In kinetic studies it is observed that peak ECF activity is released prior to the maximum of lysosomal enzyme release with the calcium ionophore, phagocytosis and arachidonic acid, while under conditions of hypotonic exposure ECF activity appears after the maximum of enzyme release. The ECF obtained by hypotonic exposure shows a fluctuating pattern with sharp peaks and steep fall-offs in activity. The ECF-release for each stimulus is temperature dependent; extracellular calcium is required when the ionophore or phagocytosis are used as stimuli, while with arachidonic acid and hypotonic exposure no extracellular calcium is necessary for ECF-release. On Sephadex G-25 each preparation of ECF eluted in the low molecular weight range at approximately 500 daltons. Eosinophils can be deactivated and cross-deactivated with the various ECF-preparations indicating either a molecular identity or a common mode of action on eosinophils.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem J. 1956 Feb;62(2):315-23 - PubMed
    1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
    1. Infect Immun. 1977 Feb;15(2):436-43 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4577-81 - PubMed
    1. Eur J Immunol. 1978 Jun;8(6):434-7 - PubMed

LinkOut - more resources